SB

Sharayu Bhuttar Jarnalsingh

Active Director Director DIN 06627384
DIN 06627384 First appointment Sep 2013 Primary industry Information Technology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2013
Shareholding value β€’β€’β€’β€’ Premium profile

About Sharayu Bhuttar Jarnalsingh

Data last updated:

Sharayu Bhuttar Jarnalsingh is a Director at Mediclix Technologies Private Limited (since 2013). The company operates in Information Technology.

DIN 06627384
Primary Designation Director
Industry Information Technology
First Appointment 28 Sep 2013
Oldest Company Age 13 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Sep 20132013Active

Directorship timeline

Open interactive timeline →
Mediclix Technologies Private Limited
Premium access

Shareholding and investment profile for Sharayu Bhuttar Jarnalsingh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sharayu Bhuttar Jarnalsingh

Sharayu Bhuttar Jarnalsingh currently holds 1 directorship: Mediclix Technologies Private Limited (Director, since 28 Sep 2013).

Sharayu Bhuttar Jarnalsingh was first appointed on 28 Sep 2013 as Director at Mediclix Technologies Private Limited.

The current boards of Sharayu Bhuttar Jarnalsingh's companies include Jarnalsingh Swaransingh Bhuttar (Mediclix Technologies Private Limited), Nishita Jarnalsingh Bhuttar (Mediclix Technologies Private Limited), Ravin Jarnalsingh Bhuttar (Mediclix Technologies Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available